Walmart settles for $50M over pharmacies filling invalid prescriptions: DOJ

August 29, 2026:

Walmart settles for $50M over pharmacies filling invalid prescriptions: DOJ

LSEG head of consumer research Jharonne Martis discusses the mind of the consumer and the Walmart overreaction on ‘Making Money.’

Walmart has agreed to pay a $50 million settlement over allegations its pharmacies were illegally filling thousands of prescriptions for opioids and other controlled substances, according to the Department of Justice (DOJ) and Drug Enforcement Administration (DEA).

The government complaint, first filed at the end of President Donald Trump’s first term and amended during former President Joe Biden’s term, accused Walmart of violating the Controlled Substances Act.

“Today’s settlement proves this department is committed to putting Americans’ flourishing first,” Associate Attorney General Stanley Woodward said in a statement. “Congress enacted laws to promote responsibility and accountability for companies who dispense controlled substances to protect Americans.

“This department will never shy away from vigorously enforcing pharmacies’ obligations to comply with those protections, ensuring that potential profits never justify aiding our nation’s opioid epidemic.”

AS A US ATTORNEY, I SEE FENTANYL’S HORRIFYING TOLL UP CLOSE; CONGRESS MUST ACT NOW

Walmart has agreed to pay a $50 million settlement over allegations its pharmacies were illegally filling thousands of prescriptions for opioids and other controlled substances, according to th DOJ and DEA. (Bob Riha, Jr./Getty Images, File / Getty Images)

The complaint alleged that Walmart had been filling invalid prescriptions with the knowledge of pharmacists and its compliance team since June 2013.

Some Walmart pharmacists reported the alleged illegal activity to Walmart’s corporate compliance team, including through thousands of “refusal-to-fill” forms, the DOJ said.

“The compliance team, however, prioritized other goals over CSA compliance,” the DOJ said.

“As one director on the compliance team acknowledged in an email, rather than analyzing the refusal-to-fill reports, the compliance team viewed ‘[d]riving sales and patient awareness,’ as ‘a far better use of our Market Directors and Market manger’s time.’”

WALMART MAKES CHANGES TO HOW MILLIONS OF CUSTOMERS CAN PAY AT CHECKOUT

Tablets of the opioid painkiller Oxycodone. (Eric Baradat/AFP via Getty Images, File / Getty Images)

Pharmacists also allegedly knowingly filled invalid prescriptions from “pill mill” prescribers or prescriptions that had red flags, such as dangerous opioid and nonopioid “cocktails,” repeated early fill requests of frequently abused drugs or high-dosages of opioids, according to the DOJ.

Ticker	Security	Last	Change	Change %
WMT	WALMART INC.	103.09	+0.46	+0.45%

As part of the settlement, the DOJ said Walmart had entered into an agreement to establish a hotline for employees and patients to report suspected illegal activity.

Some Walmart pharmacists reported the alleged illegal activity to the retail giant’s corporate compliance team. (iStock / iStock)

The company must also proactively monitor pharmacy dispensing patterns.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Walmart did not immediately respond to FOX Business’ request for comment.

Source link

tags

Abkhazia Afghanistan Africa Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Costa Rica Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Fiji Finland France French Polynesia Gabon Gambia Georgia Germany Ghana Greece Grenada Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea North Macedonia Northern Cyprus Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Republic of the Congo Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Korea South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Transnistria Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda UK Ukraine United Arab Emirates Uruguay USA Uzbekistan Vanuatu Vatican City Venezuela Vietnam Western Sahara Yemen Zambia Zimbabwe